Advanced testicular cancer: treatment choices in the "land of plenty"

Advanced prostate cancer: an update.

Reviews in urology·2006

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer.

Urology·2001

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.

The Journal of urology·2001

Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.

Molecular urology·2000

Genitourinary cancers in older adults.

Clinics in geriatric medicine·1998

Comparison of perspectives on prostate cancer: analyses of survey data.

Urology·1997

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Art as a Shared Space: Tracing the Unseen Through a Body Map.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Nivolumab dose stewardship in routine Oncology practice: a real-world health-economic simulation.

Expert review of pharmacoeconomics & outcomes research·2026

Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.

Revista do Colegio Brasileiro de Cirurgioes·2026

An Optimized Cancer Cachexia Research Model.

Current protocols·2026

Vitamin C for the prevention of complex regional pain syndrome after foot and ankle fractures or surgery: a systematic review.

European review for medical and pharmacological sciences·2026

Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention.

Cancer immunology research·2026

Advanced testicular cancer: treatment choices in the "land of plenty"

Related Experiment Videos

Related Concept Videos

Advanced prostate cancer: an update.

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer.

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.

Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.

Genitourinary cancers in older adults.

Comparison of perspectives on prostate cancer: analyses of survey data.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4.

Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study.

KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non-Small Cell Lung Cancer.

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0.

Art as a Shared Space: Tracing the Unseen Through a Body Map.

Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.

Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Nivolumab dose stewardship in routine Oncology practice: a real-world health-economic simulation.

Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.

An Optimized Cancer Cachexia Research Model.

Vitamin C for the prevention of complex regional pain syndrome after foot and ankle fractures or surgery: a systematic review.

Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention.

Advanced testicular cancer: treatment choices in the "land of plenty"

Related Experiment Videos

Related Concept Videos

Related Articles